Semaglutide in Patients with Kidney Failure and Obesity Undergoing Dialysis and Wishing to Be Transplanted

In a small prospective study, weekly semaglutide produced meaningful weight loss in dialysis patients who had been refused transplant listing because of obesity, and helped a few become candidates for transplant reconsideration.